With eight COVID-19 vaccines in human testing and headlines touting their progress each day, a leading U.S. health official voiced some […]

Nearly four years removed from a disastrous sales fraud probe and an overhaul of its senior leadership, Alexion […]

After scoring an early authorization for its COVID-19 therapy remdesivir, Gilead Sciences has been on the hunt for […]

Peptides represent a billion-dollar market in the pharmaceutical industry, but they can generally only be taken as injections […]

The UK government must alter its current strategy for tackling covid-19 or face a further wave of infections […]

A GP who was suspended for forging his supervisor’s signature when he was a trainee may resume work […]

The coronavirus pandemic has exposed the vulnerability and weaknesses of already fragile global food systems, say the authors […]

Indian drugmaker Dr. Reddy’s Laboratories has had its share of run-ins with the FDA over manufacturing problems at a […]

Sanofi is touting a clinical victory that puts recently approved Sarclisa—in a regimen that also contains Amgen’s Kyprolis—on […]

Regeneron has been at the forefront of the COVID-19 fight for months with partnered med Kevzara in clinical trials […]